Inhibition of Latent Membrane Protein 1 Impairs the Growth and Tumorigenesis of Latency II Epstein-Barr Virus-Transformed T Cells

Ítems similars

• Autoactivation of the Epstein-Barr Virus Oncogenic Protein LMP1 during Type II Latency through Opposite Roles of the NF-κB and JNK Signaling Pathways
  per: Goormachtigh, Gautier, et al.
  Publicat: (2006)
• Human Monocytic Cell Lines Transformed In Vitro by Epstein-Barr Virus Display a Type II Latency and LMP-1-Dependent Proliferation
  per: Masy, Eric, et al.
  Publicat: (2002)
• LMP1-Induced Cell Death May Contribute to the Emergency of Its Oncogenic Property
  per: Brocqueville, Guillaume, et al.
  Publicat: (2013)
• Molecular Basis of Cytotoxicity of Epstein-Barr Virus (EBV) Latent Membrane Protein 1 (LMP1) in EBV Latency III B Cells: LMP1 Induces Type II Ligand-Independent Autoactivation of CD95/Fas with Caspase 8-Mediated Apoptosis
  per: Le Clorennec, Christophe, et al.
  Publicat: (2008)
• c-Myc and Rel/NF-κB Are the Two Master Transcriptional Systems Activated in the Latency III Program of Epstein-Barr Virus-Immortalized B Cells
  per: Faumont, Nathalie, et al.
  Publicat: (2009)